首站-论文投稿智能助手
典型文献
Targeting the COP9 signalosome for cancer therapy
文献摘要:
The COP9 signalosome (CSN) is a highly conserved protein complex composed of 8 subunits (CSN1 to CSN8). The individual subunits of the CSN play essential roles in cell proliferation, tumorigenesis, cell cycle regulation, DNA damage repair, angiogenesis, and microenvironmental homeostasis. The CSN complex has an intrinsic metalloprotease that removes the ubiquitin-like activator NEDD8 from cullin-RING ligases (CRLs). Binding of neddylated CRLs to CSN is sensed by CSN4 and communicated to CSN5 with the assistance of CSN6, thus leading to the activation of deneddylase. Therefore, CSN is a crucial regulator at the intersection between neddylation and ubiquitination in cancer progression. Here, we summarize current understanding of the roles of individual CSN subunits in cancer progression. Furthermore, we explain how the CSN affects tumorigenesis through regulating transcription factors and the cell cycle. Finally, we discuss individual CSN subunits as potential therapeutic targets to provide new directions and strategies for cancer therapy.
文献关键词:
作者姓名:
Wenqi Du;Ruicheng Zhang;Bilal Muhammad;Dongsheng Pei
作者机构:
Department of Pathology,Xuzhou Medical University,Xuzhou 221004,China;Department of Human Anatomy,Xuzhou Medical University,Xuzhou 221004,China;Department of Neurology,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221006,China
引用格式:
[1]Wenqi Du;Ruicheng Zhang;Bilal Muhammad;Dongsheng Pei-.Targeting the COP9 signalosome for cancer therapy)[J].癌症生物学与医学(英文版),2022(05):573-590
A类:
COP9,signalosome,CSN1,CSN8,CRLs,neddylated,CSN4,CSN5,CSN6,deneddylase
B类:
Targeting,cancer,therapy,highly,conserved,protein,complex,composed,subunits,individual,play,essential,roles,cell,proliferation,tumorigenesis,cycle,regulation,damage,repair,angiogenesis,microenvironmental,homeostasis,has,intrinsic,metalloprotease,that,removes,like,activator,NEDD8,from,cullin,RING,ligases,Binding,sensed,by,communicated,assistance,thus,leading,activation,Therefore,crucial,regulator,intersection,between,neddylation,ubiquitination,progression,Here,summarize,current,understanding,Furthermore,explain,how,affects,through,regulating,transcription,factors,Finally,discuss,potential,therapeutic,targets,provide,new,directions,strategies
AB值:
0.48897
相似文献
AMP-activated protein kinase β1 or β2 deletion enhances colon cancer cell growth and tumorigenesis
Fuli Shi;Zhimin Tang;Shanshan Jiang;Zhijuan Xiong;Wansi Zhang;Yuanjun Li;Hui Lin;Zhijun Luo;Ying Ying-Jiangxi Medical Center for Major Public Health Events,the First Affiliated Hospital of Nanchang University,Nanchang 330006,China;Department of Immunobiology,College of Life Science and Technology,Jinan University,Guangzhou 510632,China;Jiangxi Province Key Laboratory of Tumor Pathogenesis and Molecular Pathology and Department of Pathophysiology,School of Basic Medical Sciences,Nanchang University,Nanchang 330006 China;Institute of Hematological Research,Shaanxi Provincial People's Hospital,Xi'an 710000,China;Departments of Gastroenterology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,China
ZNF3 regulates proliferation,migration and invasion through MMP1 and TWIST in colorectal cancer
Le Du;Ning Liu;Jianfeng Jin;Meng Cao;Yuantian Sun;Xinzheng Gao;Banzhan Ruan;Shangfeng Yang;Dongsheng Ge;Yingzhuan Ye;Yinxi Zhou;Erfei Chen;Jin Yang-Hainan Provincial Key Laboratory of Carcinogenesis and Intervention;Department of Biology,Hainan Medical University,Haikou 571199,China;Department of Gastrointestinal Surgery,Hainan General Hospital,Hainan Affiliated Hospital of Hainan Medical University,Haikou 571199,China;Department of Biochemistry and Molecular Biology,Hainan Medical University,Haikou 571199,China;College of Biomedical Information and Engineering,Hainan Medical University,Haikou 571199,China;Key Laboratory of Resources Biology and Biotechnology in Western China,Ministry of Education,College of Life Sciences,Northwest University,Xi'an 710069,China
P300/CBP inhibition sensitizes mantle cell lymphoma to PI3Kδ inhibitor idelalisib
Xiao-ru Zhou;Xiao Li;Li-ping Liao;Jie Han;Jing Huang;Jia-cheng Li;Hong-ru Tao;Shi-jie Fan;Zhi-feng Chen;Qi Li;Shi-jie Chen;Hong Ding;Ya-xi Yang;Bing Zhou;Hua-liang Jiang;Kai-xian Chen;Yuan-yuan Zhang;Chuan-xin Huang;Cheng Luo-Drug Discovery and Design Center,The Center for Chemical Biology,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;School of Life Science and Technology,ShanghaiTech University,Shanghai 200031,China;Department of Medicinal Chemistry,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Shanghai Institute of Immunology and Department of Immunology and Microbiology,Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education,Faculty of Basic Medicine,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。